BioClinica Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioClinica Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7532
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies, Inc., is a clinical trials services provider. The company’s cloud-based offerings comprise medical image management solutions; electronic data capture (EDC) solutions; clinical data management; clinical trial management systems (CTMS); and eClinical solutions. It also offers cardiac safety monitoring services such as ECG analysis and Digital Holter analysis, TQT study, blood pressure and pulse wave analysis and medical imaging. BioClinica offers its services to pharmaceutical, biotechnology, medical device companies and contract research organizations. The company operates through research locations in in North America, Latin America, Europe and Asia. BioClinica is headquartered in Doylestown, Pennsylvania, the US.

BioClinica Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
BioClinica Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
BioClinica Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
BioClinica Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
BioClinica Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Clinverse Raises US$3.8 Million In Series B Financing 11
Private Equity 12
Cinven Acquires Bioclinica 12
JLL Partners Completes Acquisition Of BioClinica, Provider Of Clinical Trial Management Solutions, For US$123 Million 13
Partnerships 15
Bioclinica Forms Partnership with ArisGlobal 15
BioClinica Enters into Partnership with arivis 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
BioClinica Enters Into Technology Integration Agreement With Mirada Medical 18
BioClinica Enters Into Technology Integration Agreement With NextDocs 19
Acquisition 20
BioClinica Acquires MDDX 20
JLL Partners May Sell BioClinica for USD1.3 Billion 21
BioClinica Acquires Blueprint Clinical 22
BioClinica Inc – Key Competitors 23
BioClinica Inc – Key Employees 24
BioClinica Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Strategy And Business Planning 29
Oct 02, 2017: Bioclinica: New Jersey Lt. Governor Kim Guadagno, clients, partners, attend open house 29
Oct 02, 2017: Bioclinica Moves to New Princeton, New Jersey Office in Response to Growth 30
Corporate Communications 31
Apr 11, 2018: Bioclinica Announces Executive Hires and Promotion 31
Nov 29, 2017: Bioclinica Appoints David Herron as CEO 32
Nov 29, 2017: Bioclinica Appoints New Chief Financial Officer, William Hogan 33
Nov 29, 2017: Bioclinica Appoints David Herron as Chief Executive Officer 34
Jun 02, 2017: Bioclinica Introduces Oncology Rescue Studies Team 35
Product News 36
Jun 25, 2018: Bioclinica Introduces Expanded and Enhanced ‘SMART’ Technology Suite Available with Medical Imaging, EDC and IRT Combined 36
Sep 25, 2017: 30 Bioclinica Scientific, Medical, Technology, and Clinical Development Experts Tapped to Present at Upcoming Industry Events 37
May 31, 2017: Bioclinica Introduces Pharmaceutical Industry’s First End-to-End Clinical Financial Lifecycle Platform 39
Other Significant Developments 40
Feb 21, 2018: Bioclinica Delivers Individual Case Safety Report (ICSR) Processing with Quality and Consistency While Crossing One Million Case Milestone in 2017 40
Nov 30, 2017: Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials 41
Jul 17, 2017: Bioclinica Announces Cube Has Joined eHealth App xChange 42
Jun 16, 2017: Bioclinica Launches Clean Patient Optics to Accelerate Database Lock and Clinical Trial Timelines 43
Apr 26, 2017: Bioclinica Launches Industry’s Only End-to-End Agile Randomization and Trial Supply Management Platform to Substantially Reduce Trial Timelines and Cos 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
BioClinica Inc, Medical Equipment, Key Facts 2
BioClinica Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
BioClinica Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
BioClinica Inc, Deals By Market, 2012 to YTD 2018 9
BioClinica Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Clinverse Raises US$3.8 Million In Series B Financing 11
Cinven Acquires Bioclinica 12
JLL Partners Completes Acquisition Of BioClinica, Provider Of Clinical Trial Management Solutions, For US$123 Million 13
Bioclinica Forms Partnership with ArisGlobal 15
BioClinica Enters into Partnership with arivis 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
BioClinica Enters Into Technology Integration Agreement With Mirada Medical 18
BioClinica Enters Into Technology Integration Agreement With NextDocs 19
BioClinica Acquires MDDX 20
JLL Partners May Sell BioClinica for USD1.3 Billion 21
BioClinica Acquires Blueprint Clinical 22
BioClinica Inc, Key Competitors 23
BioClinica Inc, Key Employees 24
BioClinica Inc, Other Locations 26
BioClinica Inc, Subsidiaries 26

List of Figures
BioClinica Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioClinica Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
BioClinica Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
BioClinica Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
BioClinica Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[BioClinica Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Telecom Corporation Limited:戦略・SWOT・企業財務分析
    China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China Telecom Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • HORNBACH-Baumarkt-AG (HBM):企業の財務・戦略的SWOT分析
    HORNBACH-Baumarkt-AG (HBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Samsung Heavy Industries Co., Ltd.
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Leukocare AG-製薬・医療分野:企業M&A・提携分析
    Summary Leukocare AG (Leukocare) is a clinical stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company offers services such as development of individual SPS formulations meeting i …
  • Rio Grande Electric Coop Inc:企業の戦略的SWOT分析
    Rio Grande Electric Coop Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • ZincX Resources Corp.:企業の戦略・SWOT・財務情報
    ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report Summary ZincX Resources Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Chokwang Paint Co Ltd (004910):企業の財務・戦略的SWOT分析
    Chokwang Paint Co Ltd (004910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ingredion Incorporated:企業の戦略・SWOT・財務情報
    Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ingredion Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • SSAB AB:企業のM&A・事業提携・投資動向
    SSAB AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SSAB AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • OK Biotech Co Ltd (4155):医療機器:M&Aディール及び事業提携情報
    Summary OK Biotech Co Ltd (OK Biotech) is a medical device manufacturing and distribution company that manufactures and distributes blood glucose monitoring devices and homecare medical products, among others. The company’s blood glucose monitoring devices include blood glucose meter systems, blood …
  • Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Stavropolenergosbyt (STSB):電力:M&Aディール及び事業提携情報
    Summary Stavropolenergosbyt, a subsidiary of Novgorodskaya energosbytovaya kompaniya is an energy and power company that supplies and distributes electricity. The company provides services such as electricity distribution, energy survey, payment information, energy audit and inspection and energy sa …
  • Abu Dhabi National Oil Co:企業の戦略的SWOT分析
    Abu Dhabi National Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Medifast Inc (MED):企業の財務・戦略的SWOT分析
    Medifast Inc (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Firstec Co., Ltd.
    Firstec Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Firstec Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Alliance Data Systems Corporation:企業の戦略・SWOT・財務情報
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mitochon Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotechnology company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products include mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stro …
  • AxoGen Inc (AXGN)-製薬・医療分野:企業M&A・提携分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions for peripheral nerve injuries. The company offers AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products. It also offers clinical researc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆